Toronto’s
healthtech industry,
in focus.

The $CAN 1,000,000 revolving LOC was secured through an agreement with Desjardins.

Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the successful completion by affiliates of Madryn Asset Management, LP (“Madryn”) of a short-form merger transaction, pursuant to which 100% ownership of the Company’s common stock is now consolidated under funds managed by Madryn (the “Short-form Merger”).

AI/ML Innovations Inc. (" AIML " or the " Company ") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement (the " Offering ")

Healwell AI has completely transformed into an AI software provider by selling its clinics and acquiring Orion Health.

Rocker Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) is pleased to announce that it has closed its non-brokered private placement of 7,428,571 units of the Company at the price of C$0.70 per Unit for gross proceeds of approximately $5,200,000.

Ventripoint Diagnostics Ltd : Announces the closing of its previously announced non-brokered private placement of an aggregate of 10,097,720 units at a price of $0.10 per Unit for aggregate gross proceeds of $1,009,772.

Conavi Medical Corp. (TSXV: CNVI) (“Conavi” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce that it has closed its previously announced equity offering for aggregate gross proceeds of approximately $12 million (the “Offering”).

Profound Medical Corp. has closed a private placement of 921,428 common shares to Canadian investors at US$7.00 per share, raising approximately US$6.45 million in gross proceeds, with the shares subject to a four-month-plus-one-day hold period under Canadian securities laws.

The divestiture of Mutuo enables HEALWELL to concentrate resources on its core digital healthcare solutions while Mutuo strengthens WELLSTAR's Nexus AI platform.

Canadian genomic health software developer PhenoTips said Wednesday that it has secured C$2 million (US$1.4 million) in an extended seed financing round.